Coronavirus disease 2019 (COVID-19) hospitalization metrics that do not account for disease severity underestimate protection provided by severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccination and boosting: A retrospective cohort study.
作者信息
Corrigan June K, La Jennifer, Fillmore Nathanael R, Do Nhan V, Brophy Mary, Doron Shira, Monach Paul A, Branch-Elliman Westyn
机构信息
Veterans' Affairs (VA) Boston Cooperative Studies Program, Boston, Massachusetts.
Department of Medicine, VA Boston Healthcare System, Boston, Massachusetts.
出版信息
Infect Control Hosp Epidemiol. 2023 Jan;44(1):149-151. doi: 10.1017/ice.2022.79. Epub 2022 May 23.
Abstract
摘要
相似文献
1
Coronavirus disease 2019 (COVID-19) hospitalization metrics that do not account for disease severity underestimate protection provided by severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccination and boosting: A retrospective cohort study.2019冠状病毒病（COVID-19）住院指标若未考虑疾病严重程度，则会低估严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗接种和加强针所提供的保护作用：一项回顾性队列研究。
Infect Control Hosp Epidemiol. 2023 Jan;44(1):149-151. doi: 10.1017/ice.2022.79. Epub 2022 May 23.
2
Associations Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants and Risk of Coronavirus Disease 2019 (COVID-19) Hospitalization Among Confirmed Cases in Washington State: A Retrospective Cohort Study.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）变异株与华盛顿州确诊病例中 2019 年冠状病毒病（COVID-19）住院风险的相关性：一项回顾性队列研究。
Clin Infect Dis. 2022 Aug 24;75(1):e536-e544. doi: 10.1093/cid/ciac279.
3
Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Residents of US Nursing Homes Before and During the Delta Variant Predominance, December 2020-November 2021.2020 年 12 月-2021 年 11 月，美国养老院居民在德尔塔变异株流行前后，接种 2019 冠状病毒病（COVID-19）疫苗对严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染的效果。
Clin Infect Dis. 2022 Oct 3;75(Suppl 2):S147-S154. doi: 10.1093/cid/ciac562.
4
Vaccination remains the first choice to control the spread of delta and other variants of severe acute respiratory coronavirus virus 2 (SARS-CoV-2).接种疫苗仍然是控制新冠病毒（SARS-CoV-2）德尔塔及其他变异毒株传播的首要选择。
Infect Control Hosp Epidemiol. 2022 Nov;43(11):1749-1750. doi: 10.1017/ice.2021.364. Epub 2021 Aug 6.
5
Effect of Influenza Vaccination on Risk of Coronavirus Disease 2019: A Prospective Cohort Study of 46 000 Healthcare Workers.流感疫苗接种对 2019 年冠状病毒病风险的影响：对 46000 名医护人员的前瞻性队列研究。
J Infect Dis. 2022 Aug 12;226(1):6-10. doi: 10.1093/infdis/jiac001.
6
SARS-CoV-2 infection and H1N1 vaccination: does a relationship between the two factors really exist? A retrospective analysis of a territorial cohort in Ferrara, Italy.SARS-CoV-2 感染和 H1N1 疫苗接种：这两个因素之间真的存在关联吗？对意大利费拉拉地区队列的回顾性分析。
Eur Rev Med Pharmacol Sci. 2021 Mar;25(6):2795-2801. doi: 10.26355/eurrev_202103_25441.
7
The Risk of Hospitalization and Mortality After Breakthrough SARS-CoV-2 Infection by Vaccine Type: Observational Study of Medical Claims Data.突破性 SARS-CoV-2 感染后不同疫苗类型的住院和死亡风险：医疗索赔数据的观察性研究。
JMIR Public Health Surveill. 2022 Nov 8;8(11):e38898. doi: 10.2196/38898.
8
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.COVID-19 病例和住院情况按 COVID-19 疫苗接种状况和既往 COVID-19 诊断情况划分-加利福尼亚州和纽约州，2021 年 5 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):125-131. doi: 10.15585/mmwr.mm7104e1.
9
Similarity of Protection Conferred by Previous SARS-CoV-2 Infection and by BNT162b2 Vaccine: A 3-Month Nationwide Experience From Israel.先前感染 SARS-CoV-2 和 BNT162b2 疫苗所产生的保护效果的相似性：来自以色列的为期 3 个月的全国经验。
Am J Epidemiol. 2022 Jul 23;191(8):1420-1428. doi: 10.1093/aje/kwac060.
10
Benefit and cost of repeating a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) polymerase chain reaction (PCR) test after the second day of hospitalization in five hospitals during various community prevalences and vaccination rates.在不同社区流行率和疫苗接种率下，五家医院在住院第二天后重复检测严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）聚合酶链反应（PCR）检测的获益和成本。
Infect Control Hosp Epidemiol. 2023 Jan;44(1):106-109. doi: 10.1017/ice.2022.157. Epub 2022 Jun 16.
引用本文的文献
1
Impact of lifting school mask mandates on community SARS-CoV-2 cases, hospitalizations, and deaths: a retrospective observational study.取消学校口罩强制令对社区严重急性呼吸综合征冠状病毒2型病例、住院率和死亡率的影响：一项回顾性观察研究。
Front Public Health. 2025 Jun 12;13:1579202. doi: 10.3389/fpubh.2025.1579202. eCollection 2025.
2
Leveraging near-real-time patient and population data to incorporate fluctuating risk of severe COVID-19: development and prospective validation of a personalised risk prediction tool.利用近乎实时的患者和人群数据纳入新冠重症波动风险：一种个性化风险预测工具的开发与前瞻性验证
EClinicalMedicine. 2025 Feb 21;81:103114. doi: 10.1016/j.eclinm.2025.103114. eCollection 2025 Mar.
3
Differentiating patients admitted primarily due to coronavirus disease 2019 (COVID-19) from those admitted with incidentally detected severe acute respiratory syndrome corona-virus type 2 (SARS-CoV-2) at hospital admission: A cohort analysis of German hospital records.在医院入院时区分主要因 2019 年冠状病毒病（COVID-19）而入院的患者和因偶然发现的严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）而入院的患者：德国医院记录的队列分析。
Infect Control Hosp Epidemiol. 2024 Jun;45(6):746-753. doi: 10.1017/ice.2024.3. Epub 2024 Feb 14.
4
Maintaining the Utility of Coronavirus Disease 2019 Pandemic Severity Surveillance: Evaluation of Trends in Attributable Deaths and Development and Validation of a Measurement Tool.维持 2019 年冠状病毒病大流行严重程度监测的实用性：归因死亡趋势评估以及测量工具的制定和验证。
Clin Infect Dis. 2023 Nov 11;77(9):1247-1256. doi: 10.1093/cid/ciad381.
5
Improving COVID-19 Disease Severity Surveillance Measures: Statewide Implementation Experience.改善 COVID-19 疾病严重程度监测措施：全州实施经验。
Ann Intern Med. 2023 Jun;176(6):849-852. doi: 10.7326/M23-0618. Epub 2023 May 16.
6
Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs Hospitals.与接受美国退伍军人事务部医院治疗的已接种疫苗成年人中 COVID-19 重症相关的因素。
JAMA Netw Open. 2022 Oct 3;5(10):e2240037. doi: 10.1001/jamanetworkopen.2022.40037.
Zotero 插件